Mounjaro (tirzepatide) remains separately indicated for glycemic control in adults with type 2 diabetes, including for pediatric patients aged 10 and older as of recent labeling updates
[15] [1] Nutritional adequacy : Reduced appetite and early satiety may lead to inadequate protein intake, vitamin deficiencies, or excessive muscle loss if not properly managed
Have already discussed GLP-1 options with their primary care provider: If your physician has discussed GLP-1 medication as potentially appropriate for your situation and you are exploring compounded options specifically, a platform with clinician oversight and multiple partner pharmacies may warrant further evaluation
Compounded medications have not been formally evaluated by the FDA for safety, quality, or effectiveness
Hou Y, Jin J, Duan H, Liu C, Chen L, Huang W et al (2022) Targeted therapeutic effects of oral inulin-modified double-layered nanoparticles containing chemotherapeutics on orthotopic colon cancer